Peritoneal Cancer Clinical Trials

141 clinical trials for Peritoneal Cancer across international registries, including 17 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib — RECRUITING · PHASE2
• Using Aspirin to Improve Immunological Features of Ovarian Tumors — RECRUITING · PHASE1
• ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer — RECRUITING · PHASE2
• Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer — RECRUITING · PHASE1
• A Study of Azenosertib (ZN-c3) in Patients With Ovarian Cancer — RECRUITING · PHASE1
• Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery — RECRUITING · PHASE2
• Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma — RECRUITING · NA
• Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes — RECRUITING · NA
• Niraparib vs Niraparib Plus Bevacizumab in Patients With Platinum/Taxane-based Chemotherapy in Advanced Ovarian Cancer — RECRUITING · PHASE3
• Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer — RECRUITING · PHASE2
• Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors — RECRUITING · PHASE1
• BP1001-A in Patients With Advanced or Recurrent Solid Tumors — RECRUITING · PHASE1
• Fluzoparib With or Without Bevacizumab for Neoadjuvant Therapy in Advanced Ovarian Cancer — RECRUITING · PHASE2
• Post Splenectomy Infections After Surgery for Peritoneal Malignancies (OPSI) — RECRUITING
• Quadratus Lumborum Block After Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy — RECRUITING · NA
• Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer — RECRUITING · PHASE2
• Development and Management of Registry in Patients With Gynecologic Cancer in Korea — RECRUITING
• A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) — NOT_YET_RECRUITING · PHASE3
• TRANScriptional Pathways Of Surgical Pain Modulated by Music Therapy Exposure (TRANSPOSE) — NOT_YET_RECRUITING · NA
• A Study of the Drug I131-Omburtamab in People With Desmoplastic Small Round Cell Tumors and Other Solid Tumors in the Peritoneum — ACTIVE_NOT_RECRUITING · PHASE2
• Genomic BRCA and Extensive ovArian Cancer Testing — COMPLETED
• Mirvetuximab Soravtansine With Bevacizumab Versus Bevacizumab as Maintenance in Platinum-sensitive Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Trial of Pembrolizumab Following Weekly Paclitaxel for Platinum-resistant Ovarian, Fallopian Tube or Peritoneal Cancer — COMPLETED · PHASE2
• Multi-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceR — COMPLETED
• A Clinical Study Evaluating a Combination of Oregovomab and Niraparib in Adult Women With Platinum Sensitive Recurrent Ovarian Cancer. — ACTIVE_NOT_RECRUITING · PHASE2
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery — ACTIVE_NOT_RECRUITING · PHASE3
• A Phase II Study Of Nivolumab/ Bevacizumab/Rucaparib — ACTIVE_NOT_RECRUITING · PHASE2
• Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases — ACTIVE_NOT_RECRUITING · PHASE2
• The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study. — COMPLETED
• Depression Treatment and Screening in Ovarian Cancer Patients — ACTIVE_NOT_RECRUITING · PHASE1
• Choices About Genetic Testing And Learning Your Risk With Smart Technology — COMPLETED · NA
• Mirvetuximab Soravtansine Monotherapy in Platinum-Sensitive Epithelial, Peritoneal, and Fallopian Tube Cancers — COMPLETED · PHASE2
• Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Nudge to Gynecologic Oncology — ACTIVE_NOT_RECRUITING · NA
• Outcomes After Secondary Cytoreductive Surgery With or Without Carboplatin Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Followed by Systemic Combination Chemotherapy for Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — COMPLETED · PHASE2
• A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression — COMPLETED · PHASE3
• MT2021-27 FT538 Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer — TERMINATED · PHASE1
• T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer — TERMINATED · PHASE1
• Body Surface Area-based vs Concentration-based Dosing of Cisplatin for Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Women With Advanced Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — COMPLETED · PHASE1
• Evaluation of GTPase Inhibition by Post-operative Intravenous Ketorolac in Ovarian Cancer Patients — COMPLETED · NA
• Tempus Priority Study: A Pan-tumor Observational Study — ACTIVE_NOT_RECRUITING
• Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer — COMPLETED
• Genetic Testing in African Americans — ACTIVE_NOT_RECRUITING · NA
• Epithelial Ovarian Cancer- Staging and Response to Chemotherapy Evaluated by PET/CT — ACTIVE_NOT_RECRUITING
• Establishment and Standardization of a Platform for In-depth Tumour Profiling (TUPRO) in Patients With Advanced and Metastatic High-Grade Adenocarcinoma of Ovarian, Tubal or Peritoneal Origin (TUPRO-Gyn) — COMPLETED
• A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα) — TERMINATED · PHASE1
• A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression — COMPLETED · PHASE3
• Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test — OTHER
• Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer — COMPLETED · PHASE1

Refine this search